Interleukin-6 identified as an important factor in hypoxia- and aldehyde dehydrogenase-based gefitinib adaptive resistance in non-small cell lung cancer cells
Shi-Min An(Shanghai Jiao Tong University), Liang Zhu(Chinese Academy of Sciences)
Cited by 14